MedTrace Logo

BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions)

NCT03475563 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-11-27

No results posted yet for this study

Summary

The BIOSS Lim C pharmacoactive Stent has characteristics of design that makes it very suitable for the treatment of bifurcational lesions . The objective of the study is providing deeper knowledge into the results of this stent in the treatment of bifurcational lesions.

Conditions

Interventions

PROCEDURE

Coronary angioplasty with stent implantation

Coronary angioplasty with BiOSS LIM C stent implantation

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Imanol Otaegui, MD · Hospital Universitari Vall d'hebron Barcelona, Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-16
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475563 on ClinicalTrials.gov